(PharmaNewsWire.Com, September 12, 2018 ) Industry Outlook and Trend Analysis
The Nerve Repair and Regeneration Market was worth USD 4.13 billion in 2014 and is expected to reach approximately USD 12.20 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 12.78% during the forecast period. The variables that add to the market development are the high rate of neurological disorders, a fluctuated product pipeline credited to the existence of key market players, and the enhanced treatment productivity for neurological scatters. Furthermore, the developing applications and treatments in treating the enthusiastically developing CNS issue, for example, Parkinson’s disease and Alzheimer’s, are further anticipated that would drive the market development over the figure time frame.
The product portion for nerve repair and regeneration market is extensively characterized into biomaterials and neurostimulation and neuromodulation devices. The last section is further sub-portioned into Deep Brain Stimulation Devices (DBS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Sacral Nerve Stimulation Devices (SNS), Gastric Electric Stimulation Devices (GES).The spinal cord stimulation fragment was one of the biggest with a share of the overall industry of more than 50% in 2015.
Surgery Outlook and Trend Analysis
The surgery section comprises of nerve grafting, direct nerve repair or neurorrhaphy, neurostimulation and neuromodulation surgery, and stem cell therapy. The stem cell therapy is one of the quickest developing application fragments.
Regional Outlook and Trend Analysis
In 2015, North America ruled the market attributable to the expanding rate of neural issue and medical coverage scope in the area. In 2015, the Patient Protection and Affordable Care Act (PPACA) expressed that 1 of 6 American was provided a Health Insurance Market place Plan and the general population who had selected the commercial centre arrangement, 87% of received monetary support.
Competitive Insights
The leading players in the market are Integra Life Sciences, St. Jude Medical, Cyberonics Inc, AxoGen Inc, Baxter International, Stryker Corporation, Medtronic, Polyganics B.V and Boston Scientific. The business benefactors have a wide product portfolio for neurological disorders. Additionally, there are innovative new items and treatments to enhance the treatment productivity and additionally tolerant comfort.
The Nerve Repair and Regeneration Market is segmented as follows-
By Product: Biomaterial Neurostimulation and neuromodulation devices Deep brain stimulation devices Sacral nerve stimulation devices Vagus nerve stimulation devices Spinal cord stimulation devices Gastric electric stimulation devices
By Surgery: Nerve grafting Neurostimulation and neuromodulation surgeries Stem cell therapy Direct nerve repair/neurorrhaphy
By Region North America U.S Canada Mexico Europe Germany France UK Italy Spain Rest of Europe Asia-Pacific Japan China Australia India South Korea Rest of Asia Pacific Rest of the World Brazil South Africa Saudi Arabia United Arab Emirates Others
Some of the key questions answered by the report are: What was the market size in 2014 and forecast from 2015 to 2023? What will be the industry market growth from 2015 to 2023? What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast? What are the major segments leading the market growth and why? Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
